Find and Pitch Jounalists, Get Your Story Covered

Tags: leadership pharma Research & Development research-development biotech

	Profile	Recent Articles on Subject
1	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: A reporter’s JPM notebook: a look ahead for biopharma VC investing - 14 days ago Listen: More tumult at BIO & coercive care for sickle cell patients - 8 months ago
2	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The biotech news stories we’re keeping an eye on - 14 days ago Eli Lilly seeks to join lawsuit on compounded drugs - 25 days ago Merck is a new year outlier with its diabetes drug - 28 days ago The biotech news you need to read today - 3 months ago Is pharma still fearful of the Inflation Reduction Act? - 6 months ago The biotech news you missed this week - 7 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 8 months ago The Senate health committee looks into its first subpoena in 40 years - about 1 year ago The biotech updates you need to read today - about 1 year ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - about 1 year ago FDA chastens pet companies over antibiotics - about 1 year ago The biotech news you missed from the weekend - about 1 year ago Novartis is building a new radioligand plant in China - about 1 year ago Johnson & Johnson bets heavy on AI-driven drug discovery - about 1 year ago Today’s biotech news roundup, in under 800 words - about 1 year ago These are the need-to-know biotech stories from this weekend - about 1 year ago Your Monday morning biotech news roundup - over 1 year ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Musk’s rare disease torpedo, hospitals’ pharma fix and other policies leaders are tracking - 15 days ago PharmaVoice’s Crystal Ball: The industry’s AI future - 25 days ago 3 closely watched drugs that failed in the clinic - about 2 months ago The big rebrand: Why these 4 biopharmas changed their name this year - about 2 months ago 2024 PharmaVoice 100s: Rare Disease Warriors - 3 months ago 2024 PharmaVoice 100s: Trailblazers - 4 months ago California is a life sciences leader. Joe Panetta has been one of its most vocal advocates. - 4 months ago What 3 layoff stories reveal about pharma’s troubles - 5 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 8 months ago Where competition is heating up in pharma - 8 months ago The biggest questions hanging over pharma in 2024 - about 1 year ago Pharma execs sound off on trends and policies they’re tracking in 2024 - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago 10 of our most read articles in 2023 - about 1 year ago Does BioMarin’s CEO shuffle signal bigger changes ahead? - about 1 year ago PharmaVoice 100s: Entrepreneurs - about 1 year ago PharmaVoice 100s: Clinical trial gurus - over 1 year ago
4	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	The most essential and memorable JPM moments, recapped - 15 days ago
5	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	The most essential and memorable JPM moments, recapped - 15 days ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	The most essential and memorable JPM moments, recapped - 15 days ago East Asians under-represented in biopharma leadership - 23 days ago Can an epilepsy drug do more than reduce seizures? - 24 days ago A key decision on compounding is expected this week - about 1 month ago STAT+: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu - 8 months ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More - 23 days ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 3 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 10 months ago STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more - 11 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - about 1 year ago
9	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 3 months ago
10	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 3 months ago

Journalists covering biopharma journalism